Bruxism, temporomandibular disorders, and pressure pain thresholds during fixed orthodontic treatment in adults: A prospective controlled cohort study

Published on April 14, 2026

Cranio. 2026 Apr 14:1-11. doi: 10.1080/08869634.2026.2651390. Online ahead of print.

ABSTRACT

OBJECTIVE: To investigate whether fixed orthodontic treatment affects sleep and awake bruxism activities, temporomandibular disorder (TMD) prevalence, and pressure pain thresholds (PPTs) of masticatory muscles in healthy adults.

METHODS: In this prospective controlled cohort study, 10 orthodontically treated adults and 10 age- and sex-matched untreated controls were assessed at baseline, 14 days, 1 month, and 6 months using 24-h electromyographic recordings of the masseter muscle, diagnostic criteria for TMD, and PPTs of masticatory muscles.

RESULTS: No significant intra- or inter-group differences emerged in sleep or awake bruxism indices or TMD prevalence. However, orthodontic patients showed greater jaw functional limitation at 1 and 6 months, together with reduced masseter, occipital, and sternocleidomastoid PPTs between 1 and 6 months.

CONCLUSIONS: Fixed multibracket therapy did not affect bruxism indices or TMD prevalence over 6 months, but was associated with transient jaw functional limitation and a modest reduction in cranio-cervical PPTs.

PMID:41979177 | DOI:10.1080/08869634.2026.2651390

Continue reading on website
Other news

It’s Official: NIH’s Small Business Program Is Back

April 14, 2026
Big news for innovators, founders, and R&D-driven small companies: NIH’s Seed Fund is back in action!  On April 14, NIH’s Seed Fund (Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs) was reauthorized for the next five years. The reauthorization restores momentum, improves the programs, and reopens pathways for both new applicants and currently funded

Does Cognitive Functional Therapy Reduce the Amount of Opioids Dispensed for Chronic Low Back Pain Over 12 Months: A Secondary Analysis From the RESTORE Trial

April 14, 2026
Eur J Pain. 2026 Apr;30(4):e70275. doi: 10.1002/ejp.70275.ABSTRACTBACKGROUND: Given the potential harms associated with opioids, interventions that can safely and effectively reduce the persistent use of opioids are important. Biopsychosocial interventions including Cognitive Functional Therapy (CFT) are effective for reducing chronic low back pain (LBP) and associated disability; however, it is u